During the past decade, Maine Children's Cancer Program conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 36 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 21 clinical trials were completed. i.e. 84% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maine Children's Cancer Program" #1 sponsor was "Children's Oncology Group" with 86 trials, followed by "National Cancer Institute (NCI)" with 33 trials sponsored, "St. Jude Children's Research Hospital" with 4 trials sponsored, "American Society of Clinical Oncology" with 1 trials sponsored and "LLS PedAL Initiative, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maine Children's Cancer Program" #1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "Children's Oncology Group" with 6 trials as a collaborator, "Seagen Inc." with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Maine Children's Cancer Program" are "Leukemia" (15 trials), "Sarcoma" (10 trials), "Recurrent Neuroblastoma" (9 trials), "Neuroblastoma" (7 trials) and "Recurrent Osteosarcoma" (7 trials). Many other conditions were trialed in "Maine Children's Cancer Program" in a lesser frequency.

Most popular intervention types in "Maine Children's Cancer Program" are "Drug" (105 trials), "Other" (55 trials), "Procedure" (51 trials), "Biological" (47 trials) and "Radiation" (44 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (33 trials), "Laboratory Biomarker Analysis" (31 trials), "Vincristine Sulfate" (30 trials), "Doxorubicin Hydrochloride" (22 trials) and "Etoposide" (21 trials). Other intervention names were less common.

The vast majority of trials in "Maine Children's Cancer Program" are 128 trials for "All" genders.

Currently, there are NaN active trials in "Maine Children's Cancer Program". undefined are not yet recruiting, 35 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Maine Children's Cancer Program, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Maine Children's Cancer Program, 11 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".